Custodia, A.; Aramburu-Núñez, M.; Correa-Paz, C.; Posado-Fernández, A.; Gómez-Larrauri, A.; Castillo, J.; Gómez-Muñoz, A.; Sobrino, T.; Ouro, A.
Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets. Biomolecules 2021, 11, 945.
https://doi.org/10.3390/biom11070945
AMA Style
Custodia A, Aramburu-Núñez M, Correa-Paz C, Posado-Fernández A, Gómez-Larrauri A, Castillo J, Gómez-Muñoz A, Sobrino T, Ouro A.
Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets. Biomolecules. 2021; 11(7):945.
https://doi.org/10.3390/biom11070945
Chicago/Turabian Style
Custodia, Antía, Marta Aramburu-Núñez, Clara Correa-Paz, Adrián Posado-Fernández, Ana Gómez-Larrauri, José Castillo, Antonio Gómez-Muñoz, Tomás Sobrino, and Alberto Ouro.
2021. "Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets" Biomolecules 11, no. 7: 945.
https://doi.org/10.3390/biom11070945
APA Style
Custodia, A., Aramburu-Núñez, M., Correa-Paz, C., Posado-Fernández, A., Gómez-Larrauri, A., Castillo, J., Gómez-Muñoz, A., Sobrino, T., & Ouro, A.
(2021). Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets. Biomolecules, 11(7), 945.
https://doi.org/10.3390/biom11070945